Contact Us
Therapeutic Drug Monitoring Global Market Report 2025
Global Therapeutic Drug Monitoring Market Report 2025

Report Price : $4490.00

Pages : 200

Format : PDF

Published : January 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Therapeutic Drug Monitoring Global Market Report 2025

By Product (Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors), By Technology (Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms), By Class Of Drug (Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs), By End-user (Hospital Laboratories, Commercial and Private Laboratories, Other End Users) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Therapeutic Drug Monitoring Market Overview

• Therapeutic Drug Monitoring market size has reached to $2.23 billion in 2024

• Expected to grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%

• Growth Driver: Organ Transplant Surge Drives Growth In Therapeutic Drug Monitoring Market

• Market Trend: Advancements In Anti-Idiotypic Antibody Technology Transforming Therapeutic Drug Monitoring

North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Therapeutic Drug Monitoring Market?

Therapeutic drug monitoring (TDM) is a clinical procedure in which a patient's bloodstream is continuously monitored for the concentration of a specific medicine to ensure that their dose regimens are functioning effectively. It is used to monitor pharmaceuticals for which target concentrations are difficult to monitor, medications with significant pharmacokinetic variability, medications with established therapeutic and negative side effects, and medications with narrow therapeutic ranges.

The main product types of therapeutic drug monitoring include consumables, equipment, immunoassay Analyzers, chromatography, and detectors. Therapeutic drug monitoring consumables are reagents and supplies that are used in conjunction with TDM assays. The different technologies used include immunoassays, chemiluminescence immunoassays, colorimetric immunoassays, fluorescence immunoassays, radioimmunoassay, other immunoassays, chromatography-ms, lc-ms and gc-mc that consists of different classes of drugs including antiseptic drugs, antibiotic drugs, immunosuppressant drugs, antiarrhythmic drugs, bronchodilator drugs, psychoactive drugs and other drugs for use in various end-users such as hospital laboratories, commercial and private laboratories, and other end-users.

Therapeutic Drug Monitoring Market Size and growth rate 2025 to 2029: Graph

What Is The Therapeutic Drug Monitoring Market Size 2025 And Growth Rate?

The therapeutic drug monitoring market size has grown strongly in recent years. It will grow from$2.23 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising incidence of chronic diseases, drug safety concerns, pharmacogenomics integration, increasing drug development, regulatory emphasis on precision medicine

What Is The Therapeutic Drug Monitoring Market Growth Forecast?

The therapeutic drug monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to expanding applications in oncology, rise in personalized medicine practices, global increase in aging population, expanded point-of-care testing, growing pharmaceutical r&d expenditure. Major trends in the forecast period include personalized medicine, technological advancements, increased drug development and usage, point-of-care testing (poct), emerging biomarkers and assay technologies.

The forecast of 11.1% growth over the next five years reflects a modest reduction of 0.2% from the previous estimate for this market.This reduction is primarily due to the impact of tariffs between the US and other countries. This is likely to directly affect the US through supply chain disruptions for chromatography columns and immunoassay reagents, sourced from key regions such as France and India, could lead to delays in critical medication level testing.The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts

What’s The Trade War Impact On Medical Equipment Industry?

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

How Is The Therapeutic Drug Monitoring Market Segmented?

1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors

2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms

3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs

4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users

Subsegments:

1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards

2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment

3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers

4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques

What Is Driving The Therapeutic Drug Monitoring Market? Organ Transplant Surge Drives Growth In Therapeutic Drug Monitoring Market

The rise in organ transplant surgeries is expected to propel the growth of the therapeutic drug monitoring market. Organ transplantation is a surgical process that transfers an organ from one individual (the donor) to another. The TDM of immunosuppressive medicines has been recognized as an effective method in managing patients undergoing solid organ transplantation. TDM optimization may result in avoiding toxic or insufficiently low-dose therapy that might result in organ rejection. For instance, in January 2023, according to an article released by the United Network for Organ Sharing, a US-based non-profit organization responsible for managing organ transplants, in 2022, in the US, 42,887 organ transplants were performed, a 3.7% increase over 2021. Therefore, the rise in organ transplant surgeries drives the therapeutic drug monitoring industry.

What Is Driving The Therapeutic Drug Monitoring Market? Increasing Consumption Of Drugs Is Anticipated To Fuel The Therapeutic Drug Monitoring Market

The increasing consumption of drugs is expected to propel the growth of the therapeutic drug monitoring market going forward. Drugs are substances used for medical purposes to diagnose, treat, or prevent diseases in humans or animals. Therapeutic drug monitoring is employed to optimize drug dosage regimens by measuring and adjusting drug concentrations in the bloodstream, ensuring efficacy while minimizing side effects. For instance, in June 2023, according to the United Nations Office on Drugs and Crime, an Austria-based specialized agency, the global estimate of people who inject drugs in 2021 was 13.2 million, 18% higher than previously estimated. Similarly, over 296 million people used drugs globally, in 2021, an increase of 23% over the previous decade. Therefore, the increasing consumption of drugs is driving the therapeutic drug monitoring industry.

Who Are The Major Players In The Global Therapeutic Drug Monitoring Market?

Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics

What Are The Key Trends Of The Global Therapeutic Drug Monitoring Market? Advancements In Anti-Idiotypic Antibody Technology Transforming Therapeutic Drug Monitoring

Major companies in the therapeutic drug monitoring market are focusing on the development of anti-idiotypic antibody technology to enhance the sensitivity and specificity of assays for accurately measuring biologic drug levels and assessing patient immune responses. Anti-idiotypic antibody technology is helpful in therapeutic drug monitoring by enabling precise detection and measurement of biologic drug levels, ensuring accurate dosing, and tracking of patient immune responses. For instance, in June 2024, Bio-Rad Laboratories, a US-based biotechnology company, launched new anti-idiotypic and anti-monomethyl auristatin E (MMAE) antibodies for bioanalytical assays, improving pharmacokinetic (PK) and antidrug-antibody (ADA) monitoring. These innovative antibodies enhance the reliability of assays for antibody-drug conjugates (ADCs) and are crucial for the therapeutic drug monitoring market, enabling precise assessments of drug levels and immune responses for optimal patient dosing.

What Are The Key Trends Of The Global Therapeutic Drug Monitoring Market? Testing Solutions To Address The Need For Timely Decision-Making

Major companies operating in the therapeutic drug monitoring market are focused on developing testing solutions such as Point-of-Care Testing (POCT) solutions to address the need for timely decision-making. A Point-of-Care Testing (POCT) solution refers to a medical diagnostic approach that allows for rapid testing and analysis of patient samples. For instance, in May 2022, THERADIAG, a France-based company that develops and markets biological diagnostic tools, launched ez-Track1, a Point-of-Care Testing (POCT) solution for therapeutic drug monitoring, catering to the growing demand for patient-centric diagnostics in the global healthcare sector. Marketed initially in Europe, ez-Track1 conducts tests with whole blood samples, delivering results within 10 minutes, enabling swift decision-making in implementing biotherapies. The CE-marked system's launch menu includes tests for Infliximab, anti-Infliximab, Adalimumab, and anti-adalimumab, with plans for rapid expansion to cover a broader range of chronic inflammatory diseases and other conditions.

Need data on a specific region in this market?

Therapeutic Drug Monitoring Market Merger And Acquisition: Sentinel Diagnostics Expands Portfolio With Acquisition Of Eureka S.R.L., Strengthening Position In Ivd Testing

In February 2023, Sentinel Diagnostics, an Italian in vitro diagnostic company, acquired Eureka S.r.l. for an undisclosed amount. This acquisition allows Sentinel Diagnostics to achieve its goal of becoming a significant producer and developer of IVD tests. Sentinel Diagnostics will be able to provide clinical laboratories with a larger selection of assays due to its expanded capabilities, ranging from high-throughput core lab tests to the most cutting-edge, specialized second-level assays. EUREKA S.r.l. is an Italian IVD chromatographic company that provides ready-to-use diagnostic kits for HPLC, GC, GC-MS, and LC-MS/MS applications for special clinical chemistry, therapeutic drug monitoring, occupational toxicology, and forensic toxicology.

Regional Analysis For The Global Therapeutic Drug Monitoring Market

North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Therapeutic Drug Monitoring Market?

The therapeutic drug monitoring market includes revenues earned by entities by providing drug monitoring, urine drug testing, drug efficacy testing, and drug toxicology. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic drug monitoring market also includes sales of Immunoassay kits, Mass spectrometry instruments, and Chromatography systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Therapeutic Drug Monitoring Industry?

The therapeutic drug monitoring market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic drug monitoring industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Therapeutic Drug Monitoring Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $2.41 billion
Revenue Forecast In 2034 $3.67 billion
Growth Rate CAGR of 11.1% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered 1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users Subsegments: 1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Therapeutic Drug Monitoring Market Characteristics

3. Therapeutic Drug Monitoring Market Trends And Strategies

4. Therapeutic Drug Monitoring Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Therapeutic Drug Monitoring Growth Analysis And Strategic Analysis Framework

5.1. Global Therapeutic Drug Monitoring PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Therapeutic Drug Monitoring Market Growth Rate Analysis

5.4. Global Therapeutic Drug Monitoring Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Therapeutic Drug Monitoring Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Therapeutic Drug Monitoring Total Addressable Market (TAM)

6. Therapeutic Drug Monitoring Market Segmentation

6.1. Global Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Consumables

Equipment

Immunoassay Analyzers

Chromatography And Detectors

6.2. Global Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Immunoassays

Chemiluminescence Immunoassays

Chemiluminescence Immunoassays

Colorimetric Immunoassays

Fluorescence Immunoassays

Radioimmunoassay

Other Immunoassays

6.3. Global Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Antiepileptic Drugs

Antibiotic Drugs

Immunosuppressant Drugs

Antiarrhythmic Drugs

Bronchodilator Drugs

Psychoactive Drugs

Other Drugs

6.4. Global Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospital Laboratories

Commercial and Private Laboratories

Other End Users

6.5. Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Reagents

Test Kits

Sample Collection Containers

Calibration Standards

6.6. Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Analyzers

Incubators

Centrifuges

Other Equipment

6.7. Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Immunoassay Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

ELISA Analyzers

Chemiluminescent Immunoassay Analyzers

Radioimmunoassay Analyzers

6.8. Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Chromatography And Detectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

High-Performance Liquid Chromatography (HPLC)

Gas Chromatography (GC)

Mass Spectrometry (MS)

Other Chromatography Techniques

7. Therapeutic Drug Monitoring Market Regional And Country Analysis

7.1. Global Therapeutic Drug Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Therapeutic Drug Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic Drug Monitoring Market

8.1. Asia-Pacific Therapeutic Drug Monitoring Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic Drug Monitoring Market

9.1. China Therapeutic Drug Monitoring Market Overview

9.2. China Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic Drug Monitoring Market

10.1. India Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic Drug Monitoring Market

11.1. Japan Therapeutic Drug Monitoring Market Overview

11.2. Japan Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic Drug Monitoring Market

12.1. Australia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic Drug Monitoring Market

13.1. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic Drug Monitoring Market

14.1. South Korea Therapeutic Drug Monitoring Market Overview

14.2. South Korea Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic Drug Monitoring Market

15.1. Western Europe Therapeutic Drug Monitoring Market Overview

15.2. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic Drug Monitoring Market

16.1. UK Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic Drug Monitoring Market

17.1. Germany Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic Drug Monitoring Market

18.1. France Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic Drug Monitoring Market

19.1. Italy Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic Drug Monitoring Market

20.1. Spain Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic Drug Monitoring Market

21.1. Eastern Europe Therapeutic Drug Monitoring Market Overview

21.2. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic Drug Monitoring Market

22.1. Russia Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic Drug Monitoring Market

23.1. North America Therapeutic Drug Monitoring Market Overview

23.2. North America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic Drug Monitoring Market

24.1. USA Therapeutic Drug Monitoring Market Overview

24.2. USA Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic Drug Monitoring Market

25.1. Canada Therapeutic Drug Monitoring Market Overview

25.2. Canada Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic Drug Monitoring Market

26.1. South America Therapeutic Drug Monitoring Market Overview

26.2. South America Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic Drug Monitoring Market

27.1. Brazil Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic Drug Monitoring Market

28.1. Middle East Therapeutic Drug Monitoring Market Overview

28.2. Middle East Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic Drug Monitoring Market

29.1. Africa Therapeutic Drug Monitoring Market Overview

29.2. Africa Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic Drug Monitoring Market Competitive Landscape And Company Profiles

30.1. Therapeutic Drug Monitoring Market Competitive Landscape

30.2. Therapeutic Drug Monitoring Market Company Profiles

30.2.1. Abbott Laboratories Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.2. F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Siemens Healthineers AG Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Sekisui Medical Co. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic Drug Monitoring Market Other Major And Innovative Companies

31.1. Buehlmann Laboratories AG

31.2. Danaher Corporation

31.3. Bio-Rad Laboratories Inc.

31.4. bioMérieux SA

31.5. Randox Laboratories Limited

31.6. Chromsystems Instruments & Chemicals GmbH

31.7. Grifols SA

31.8. Merck KGaA

31.9. BioChem Pharmaceuticals

31.10. Beckman Coulter Inc.

31.11. DiaSorin S.p.A.

31.12. Hologic Inc.

31.13. Immunodiagnostic Systems Holdings plc

31.14. Kronus Inc.

31.15. QuidelOrtho Corporation

32. Global Therapeutic Drug Monitoring Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Drug Monitoring Market

34. Recent Developments In The Therapeutic Drug Monitoring Market

35. Therapeutic Drug Monitoring Market High Potential Countries, Segments and Strategies

35.1 Therapeutic Drug Monitoring Market In 2029 - Countries Offering Most New Opportunities

35.2 Therapeutic Drug Monitoring Market In 2029 - Segments Offering Most New Opportunities

35.3 Therapeutic Drug Monitoring Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Immunoassay Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Chromatography And Detectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Global Therapeutic Drug Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: Global Therapeutic Drug Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: China, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: China, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: China, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: India, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: India, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: India, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Japan, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Japan, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Japan, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Australia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Australia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: Australia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: UK, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: UK, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: UK, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: Germany, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: Germany, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Germany, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: France, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: France, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: France, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Italy, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Italy, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Italy, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Spain, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Spain, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Spain, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: Russia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: Russia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: Russia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: North America, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: North America, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: North America, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: USA, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: USA, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: USA, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: Canada, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: Canada, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Canada, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: South America, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: South America, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: South America, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 76: Africa, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 77: Africa, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 78: Africa, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 79: Abbott Laboratories Inc. Financial Performance
  • Table 80: F. Hoffmann-La Roche AG Financial Performance
  • Table 81: Siemens Healthineers AG Financial Performance
  • Table 82: Thermo Fisher Scientific Inc. Financial Performance
  • Table 83: Sekisui Medical Co. Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Therapeutic Drug Monitoring Market, Segmentation By End-user, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Equipment, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Immunoassay Analyzers, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Global Therapeutic Drug Monitoring Market, Sub-Segmentation Of Chromatography And Detectors, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Global Therapeutic Drug Monitoring Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: Global Therapeutic Drug Monitoring Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: Asia-Pacific, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: China, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: China, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: China, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: India, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: India, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: India, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Japan, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Japan, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Japan, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Australia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Australia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: Australia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Indonesia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: South Korea, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Western Europe, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: UK, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: UK, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: UK, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: Germany, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: Germany, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Germany, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: France, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: France, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: France, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Italy, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Italy, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Italy, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Spain, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Spain, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Spain, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: Eastern Europe, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: Russia, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: Russia, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: Russia, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: North America, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: North America, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: North America, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: USA, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: USA, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: USA, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: Canada, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: Canada, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Canada, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: South America, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: South America, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: South America, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Brazil, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: Middle East, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 76: Africa, Therapeutic Drug Monitoring Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 77: Africa, Therapeutic Drug Monitoring Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 78: Africa, Therapeutic Drug Monitoring Market, Segmentation By Class Of Drug, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 79: Abbott Laboratories Inc. Financial Performance
  • Figure 80: F. Hoffmann-La Roche AG Financial Performance
  • Figure 81: Siemens Healthineers AG Financial Performance
  • Figure 82: Thermo Fisher Scientific Inc. Financial Performance
  • Figure 83: Sekisui Medical Co. Financial Performance

Frequently Asked Questions

Therapeutic drug monitoring (TDM) is a clinical procedure in which a patient's bloodstream is continuously monitored for the concentration of a specific medicine to ensure that their dose regimens are functioning effectively. It is used to monitor pharmaceuticals for which target concentrations are difficult to monitor, medications with significant pharmacokinetic variability, medications with established therapeutic and negative side effects, and medications with narrow therapeutic ranges. For further insights on this market, request a sample here

The market major growth driver - Organ Transplant Surge Drives Growth In Therapeutic Drug Monitoring Market. For further insights on this market, request a sample here

The therapeutic drug monitoring market size has grown strongly in recent years. It will grow from $2.23 billion in 2024 to $2.41 billion in 2025 at a compound annual growth rate (CAGR) of 8.1%. The growth in the historic period can be attributed to rising incidence of chronic diseases, drug safety concerns, pharmacogenomics integration, increasing drug development, regulatory emphasis on precision medicine. The therapeutic drug monitoring market size is expected to see rapid growth in the next few years. It will grow to $3.67 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to expanding applications in oncology, rise in personalized medicine practices, global increase in aging population, expanded point-of-care testing, growing pharmaceutical r&d expenditure. Major trends in the forecast period include personalized medicine, technological advancements, increased drug development and usage, point-of-care testing (poct), emerging biomarkers and assay technologies. For further insights on this market, request a sample here

The therapeutic drug monitoringmarket covered in this report is segmented –
1) By Product: Consumables, Equipment, Immunoassay Analyzers, Chromatography And Detectors
2) By Technology: Immunoassays, Chemiluminescence Immunoassays, Chemiluminescence Immunoassays, Colorimetric Immunoassays, Fluorescence Immunoassays, Radioimmunoassay, Other Immunoassays, Chromatography-Ms, Lc-Ms, Gc-Ms
3) By Class Of Drug: Antiepileptic Drugs, Antibiotic Drugs, Immunosuppressant Drugs, Antiarrhythmic Drugs, Bronchodilator Drugs, Psychoactive Drugs, Other Drugs
4) By End-user: Hospital Laboratories, Commercial and Private Laboratories, Other End Users Subsegments:
1) By Consumables: Reagents, Test Kits, Sample Collection Containers, Calibration Standards
2) By Equipment: Analyzers, Incubators, Centrifuges, Other Equipment
3) By Immunoassay Analyzers: ELISA Analyzers, Chemiluminescent Immunoassay Analyzers, Radioimmunoassay Analyzers
4) By Chromatography And Detectors: High-Performance Liquid Chromatography (HPLC), Gas Chromatography (GC), Mass Spectrometry (MS), Other Chromatography Techniques For further insights on this market,
request a sample here

North America was the largest region in the therapeutic drug monitoring market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global therapeutic drug monitoring market report during the forecast period. The regions covered in the therapeutic drug monitoring market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the therapeutic drug monitoring market include Abbott Laboratories Inc., F. Hoffmann-La Roche AG, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Sekisui Medical Co., Buehlmann Laboratories AG, Danaher Corporation, Bio-Rad Laboratories Inc., bioMérieux SA, Randox Laboratories Limited, Chromsystems Instruments & Chemicals GmbH, Grifols SA, Merck KGaA, BioChem Pharmaceuticals, Beckman Coulter Inc., DiaSorin S.p.A., Hologic Inc., Immunodiagnostic Systems Holdings plc, Kronus Inc., QuidelOrtho Corporation, Sysmex Corporation, TDM Solutions Inc., Theradiag, Tosoh Bioscience LLC, Trinity Biotech plc, Associated Regional and University Pathologists Inc., Mayo Clinic Laboratories, Quest Diagnostics . For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Back to top